Court Rules For Pfizer In Accupril Patent Suit

Law360, New York (July 1, 2004, 12:00 AM EDT) -- A U.S. district court judge has ruled that Pfizer’s patents for Accupril are valid, dealing Israeli drug maker Teva a blow in its efforts to market a generic version of the $600 million blood pressure medicine.

In a June 29 decision, Judge Dickinson R. Debevoise of the U.S. District Court for the District of New Jersey held that Warner-Lambert's patent on a stable formulation of quinapril, the generic name of the drug, was valid, infringed and enforceable against Teva, Pfizer said.

The decision affirmed the court's...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.